News

October 17, 2007 - After a three-week trial, a jury rendered a verdict of "willful" patent infringement in a dispute filed against CHF Technologies, Inc., d/b/a BioVentrix, after Chase Medical sued BioVentrix alleging its Blue Egg Sizer, a hollow, blue silicone device used to guide surgeons in surgically resizing the heart, infringed patents held by Chase.

Home October 16, 2007
Home
Technology

Building on the foundation of GE Healthcare’s CT platform, the LightSpeed VCT XT is reportedly capable of capturing ...

Home October 16, 2007
Home
News

October 17, 2007 — The first trial to test whether medicated, drug-eluting (dispensing), stents can benefit patients who ...

Home October 16, 2007
Home
Technology

The KODAK DIRECTVIEW Classic and Elite Computed Radiography Systems are compact, floor standing, single-cassette CR ...

Home October 16, 2007
Home
News

October 17, 2007 – Siemens Medical Solutions today announced that it recently received FDA 510(k) clearance for a 1.5 ...

Home October 16, 2007
Home
Technology

Siemens Medical Solutions received FDA 510(k) clearance for a 1.5 Tesla (T) magnetic resonance imaging (MRI) system that is reportedly more affordable, allowing providers to upgrade from low-field MRI systems or to add an MRI system for the first time.

Home October 16, 2007
Home
News

October 17, 2007 - Compared to bare metal stents, in patients with acute myocardial infarction, sirolimus-eluting stent ...

Home October 16, 2007
Home
Technology

The Philips Step and Shoot Cardiac solution has reportedly been shown to save up to 80 percent of the dose in a cardiac exam. As the newest cardiac imaging innovation for the Philips Brilliance CT 64-channel scanner, it provides high quality CT images at low radiation dose. An axial prospective ECG-gated acquisition technique reportedly achieves full heart coverage within a short breath-hold.

Home October 16, 2007
Home
News

October 17, 2007 — Patients with heart disease who undergo coronary angioplasty have an equivalent risk of death and heart attack as patients who undergo coronary bypass surgery, according to Stanford University School of Medicine researchers.

Home October 16, 2007
Home
News

October 16, 2007 — In response to Medtronic’s decision to voluntarily suspend its Sprint Fidelis defibrillation leads, the Heart Rhythm Society (HRS) made a statement to underscore the importance of the society’s task force recommendations for the surveillance, analysis and performance reporting of pacemakers and implantable cardioverter defibrillators (ICDs).

Home October 15, 2007
Home
Feature | Christine Wyrick, M.D., Adebola Adesanya, M.D., Girish P. Joshi, MB BS, M.D., FFARCSI

Despite advances in our understanding of the pathophysiology of pain and the pharmacology of analgesic drugs, as well as increasing emphasis on adequate pain management [1], pain control remains inadequate in hospitalized patients.

Home October 15, 2007
Home
News

October 16, 2007 - MIV Therapeutics Inc., a developer of coatings and drug delivery systems for cardiovascular stents ...

Home October 15, 2007
Home
News

October 16, 2007 – Celera developed a five-gene genetic risk score based on five variant genes that predict risk for coronary heart disease (CHD), according to a study published in the October 2007 edition of Genetics in Medicine, marking the potential development of personalized disease management in the cardiovascular arena.

Home October 15, 2007
Home
Feature | Maureen Leahy-Patano

The clinical definition of intraoperative awareness — consciousness during general anesthesia — is a seemingly simple explanation for a complex, and controversial, phenomenon. Opinions surrounding how often intraoperative awareness, also described as anesthesia awareness, occurs, its implications for victims, as well as the best methods for prevention are varied.

Home October 15, 2007
Home
News

October 16, 2007 – Medtronic Inc. said in a statement that it has voluntarily suspended worldwide distribution of the Sprint Fidelis family of defibrillation leads because of the potential for lead fractures, and the company recommends that physicians do no perform new implants of the leads (Sprint Fidelis Models: 6930, 6931, 6948, 6949).

Home October 15, 2007
Home
Subscribe Now